Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165949 | SCV000216705 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-09-24 | criteria provided, single submitter | clinical testing | The p.C124R pathogenic mutation (also known as c.370T>C), located in coding exon 4 of the BMPR1A gene, results from a T to C substitution at nucleotide position 370. The cysteine at codon 124 is replaced by arginine, an amino acid with highly dissimilar properties. This alteration has been identified in individuals meeting diagnostic criteria for juvenile polyposis syndrome (Zhou XP et al. Am J Hum Genet. 2001 Oct;69(4):704-11; Ambry internal data) and co-segregated with disease in one family tested in our laboratory. This amino acid position is highly conserved on sequence alignment. The p.C124R variant results in the loss of the Cys residue and alters the folding of the BMPR1A extracellular domain (Ambry internal structural analysis). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. |
Gene |
RCV001836704 | SCV002097427 | likely pathogenic | not provided | 2022-02-07 | criteria provided, single submitter | clinical testing | Identified in a patients with a personal or family history consistent with pathogenic variants in this gene referred for genetic testing at GeneDx and in published literature (Zhou 2001); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12136244, 11536076, 12761718, 15235019, 26986070, 30884445, 29745898, 10881198, 22799562, 23433720) |
Baylor Genetics | RCV003473059 | SCV004212663 | likely pathogenic | Polyposis syndrome, hereditary mixed, 2 | 2022-05-04 | criteria provided, single submitter | clinical testing | |
OMIM | RCV001797979 | SCV000028926 | pathogenic | Juvenile polyposis syndrome | 2001-10-01 | no assertion criteria provided | literature only |